PLEKHA1

pleckstrin homology domain containing A1, the group of Pleckstrin homology domain containing|MicroRNA protein coding host genes

Basic information

Region (hg38): 10:122374696-122432354

Links

ENSG00000107679NCBI:59338OMIM:607772HGNC:14335Uniprot:Q9HB21AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PLEKHA1 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PLEKHA1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
23
clinvar
2
clinvar
25
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
1
clinvar
1
Total 0 0 23 2 1

Variants in PLEKHA1

This is a list of pathogenic ClinVar variants found in the PLEKHA1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-122393318-G-A not specified Uncertain significance (Nov 12, 2021)2260725
10-122397973-A-C not specified Uncertain significance (Nov 10, 2022)2325927
10-122400343-G-A not specified Uncertain significance (Oct 03, 2022)2406435
10-122406615-A-G not specified Uncertain significance (Feb 16, 2023)3214743
10-122406620-C-G not specified Uncertain significance (Jul 26, 2022)2211096
10-122407996-C-T Benign (Feb 18, 2020)1238542
10-122412947-A-C not specified Likely benign (May 25, 2022)2223190
10-122412958-C-A not specified Uncertain significance (Dec 28, 2022)2340189
10-122412965-C-G not specified Uncertain significance (Nov 01, 2022)2321811
10-122412965-C-T not specified Uncertain significance (Nov 03, 2022)2400875
10-122412988-G-C not specified Uncertain significance (Nov 30, 2022)2330167
10-122413044-A-G Uncertain significance (Jan 01, 2023)2640903
10-122417921-T-C not specified Uncertain significance (May 24, 2023)2551358
10-122424194-G-T Benign (Dec 31, 2019)779937
10-122424214-C-G not specified Uncertain significance (Dec 05, 2022)2332407
10-122424217-G-A not specified Uncertain significance (Jun 03, 2024)3307476
10-122424937-C-T not specified Uncertain significance (Nov 22, 2021)2362364
10-122424952-A-T not specified Uncertain significance (Mar 25, 2024)3307478
10-122426942-G-T not specified Uncertain significance (Oct 04, 2022)2316250
10-122427014-G-A not specified Uncertain significance (Mar 14, 2023)2496358
10-122427029-T-G not specified Uncertain significance (Nov 27, 2023)3214745
10-122429654-C-T not specified Uncertain significance (Jul 13, 2021)2343201
10-122429664-G-A not specified Uncertain significance (Feb 28, 2024)3214746
10-122429673-A-G not specified Likely benign (May 11, 2022)2312244
10-122429699-A-G not specified Uncertain significance (May 26, 2024)3307479

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PLEKHA1protein_codingprotein_codingENST00000368990 1157656
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.0002350.9961256580901257480.000358
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.6562072350.8800.00001332663
Missense in Polyphen81105.660.766621261
Synonymous0.02928282.30.9960.00000504750
Loss of Function2.551023.30.4290.00000120271

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0003330.000333
Ashkenazi Jewish0.001090.00109
East Asian0.0002180.000217
Finnish0.0001390.000139
European (Non-Finnish)0.0003960.000396
Middle Eastern0.0002180.000217
South Asian0.0006220.000621
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Binds specifically to phosphatidylinositol 3,4- diphosphate (PtdIns3,4P2), but not to other phosphoinositides. May recruit other proteins to the plasma membrane. {ECO:0000269|PubMed:11001876, ECO:0000269|PubMed:11513726, ECO:0000269|PubMed:14516276}.;
Pathway
Metabolism of lipids;Metabolism;BCR;Synthesis of PIPs at the plasma membrane;Class I PI3K signaling events;PI Metabolism;Phospholipid metabolism (Consensus)

Recessive Scores

pRec
0.165

Intolerance Scores

loftool
0.845
rvis_EVS
-0.47
rvis_percentile_EVS
23.43

Haploinsufficiency Scores

pHI
0.319
hipred
Y
hipred_score
0.589
ghis
0.550

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.719

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Plekha1
Phenotype
growth/size/body region phenotype; endocrine/exocrine gland phenotype; muscle phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; skeleton phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); digestive/alimentary phenotype;

Gene ontology

Biological process
luteinization;phosphatidylinositol biosynthetic process;spermatogenesis;androgen metabolic process;estrogen metabolic process;post-embryonic development;phosphatidylinositol 3-kinase signaling;ruffle organization;Leydig cell differentiation;multicellular organism growth;establishment of protein localization;platelet-derived growth factor receptor signaling pathway;skeletal system morphogenesis;B cell receptor signaling pathway;negative regulation of protein kinase B signaling;roof of mouth development;face morphogenesis;cellular response to hydrogen peroxide
Cellular component
nucleus;nucleoplasm;cytoplasm;cytosol;plasma membrane;membrane;ruffle membrane;extracellular exosome
Molecular function
protein binding;PDZ domain binding;phosphatidylinositol-3,4-bisphosphate binding